EGFR-TKIs resistance - Globe Thesis

Keyword [EGFR-TKIs resistance] Result: 1 - 20 \| Page: 1 of 2
1.	Development Of EGFR-TKIs Drug-Resistant NSCLC Cell Lines In Vitro And Investigation On The EGFR-TKIs Resistance Mechanism
2.	Construction And Identification Of Anti-EGFR Single Chain Fragment Antibody(scFv)and Inhibits The Proliferation Of NSCLC Cells And Tumor Growth By ScFv-mediate SiRNA
3.	TOPK Promotes Resistance To EGFR Tyrosine Kinase Inhibitors By Phosphorylating And Activating C-Jun In Lung Cancer
4.	EGFR-TKIs Resistance Promotes Immune Escape Of Lung Cancer Cells Through Increasing PD-L1 Expression
5.	Study On The Correlation Between C-met Expression And EGFR-TKIs Resistance In Lung Adenocarcinoma
6.	Expressions And Clinical Significance Of Notch1 And IGF-1 In Different EGFR Gene Status Of Non-small Cell Lung Cancer
7.	Acquired EGFR-TKIs Resistance In Non-small Lung Cancer By Lysosomal Deficiency-induced SQSTM1 Accumulation
8.	A Retrospective Study Of The Characteristics Of Chinese Medicine Combined With EGFR-TKIs To Delay The Late NSCLC Resistance Time
9.	Study Of Relation Between PD-L1 Expression And EGFR-TKIs Resistance Mechanism In Non-small Cell Lung Cancer
10.	Inhibition Of Nuclear Factor-kB Improves Sensitivity To Irradiation And EGFR-TKIs,and Decreases Irradiation-induced Lung Toxicity
11.	Mechanisms Of Hedgehog Signaling Pathway To Acquire EGFR-TKIs Resistance In EGFR-mutated Non-small Cell Lung Cancer Patients With Brain Metastasis
12.	Cytoplasmic P120ctn Promotes Tyrosine Kinase Inhibitor Resistance In Lung Cancer Cells By Activating PAKs And Mediated EGFR Downstream Activation
13.	MiR-625-3p Modulates Gefitinib Resistance Through AXL In Non-small Cell Lung Cancer
14.	Clinical Study Of Apatinib Mesylate In Treatment Of Advanced Lung Adenocarcinoma With EGFR-TKIs Resistance
15.	Study On EGFR-TKIs Resistance And BIN1 Expression In Lung Adenocarcinoma
16.	The Mechanism Of EGFR-TKIs Resistance In HOTAIR In Non-small Cell Lung Cancer
17.	Correlation Between Clinical Features Of Patients With Advanced NSCLC After The First Generation EGFR-TKIS Resistance And T790M Mutation,the Efficacy Of Osimertinib
18.	Effect Of Silencing FGL1 On Sensitivity Of Gefitinib In Lung Adenocarcinoma Cells
19.	Observation On The Efficacy Of Three Treatment Options For T790M Negative Advanced NSCLC Patients After First Generation EGFR-TKIs Resistance
20.	Investigation On The Mechanism Of PIK3CA Mutation To EGFR-TKIs Resistance In Non-small Cell Lung Cancer
<<First <Prev Next> Last>> Jump to